Dr. Jose F. Leis, MD
Hematology & Oncology (Hematology & Oncology Physician)
13400 E Shea Blvd
Scottsdale, AZ 85259
Who else practices at this address →
Maricopa County includes primary care (13% of residents) and dental (0% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Arizona College of Medicine (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 479
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: University of Arizona College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
AZ license 36501 · OR license MD20538
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mayo Clinic Hospital Phoenix, AZ
Medical groups
- Mayo Clinic Arizona (1,626 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 479
- Services billed
- 48,189
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,360 | 37 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,700 | 12 |
| Injection, fosaprepitant, 1 mg | 5,550 | 33 |
| Injection, pembrolizumab, 1 mg | 4,002 | 18 |
| Injection, azacitidine, 1 mg | 3,100 | 14 |
| Injection, paclitaxel, 1 mg | 3,060 | 13 |
| Injection, denosumab, 1 mg | 1,500 | 14 |
| Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 830 | 15 |
| Injection, dexamethasone sodium phosphate, 1 mg | 772 | 58 |
| Injection, ondansetron hydrochloride, per 1 mg | 740 | 65 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Acyclovir Other prescribers in Scottsdale, AZ | 111 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Scottsdale, AZ | 61 |
| Imbruvica (ibrutinib) | 54 |
| Brukinsa (zanubrutinib) | 37 |
| Venclexta (venetoclax) | 36 |
| Allopurinol Other prescribers in Scottsdale, AZ | 30 |
| Jaypirca (pirtobrutinib) | 29 |
| Jakafi (ruxolitinib phosphate) | 17 |
| Prochlorperazine Maleate Other prescribers in Scottsdale, AZ | 16 |
| Imatinib Mesylate | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $124,402 in research payments for these studies, mostly to the institutions running them.
- A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Eli Lilly and Company · Active, not recruiting · NCT04965493
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.